Search Results - ЭКСТРАКОРПОРАЛЬНОЕ ОПЛОДОТВОРЕНИЕ

1

ЭКСТРАКОРПОРАЛЬНОЕ ОПЛОДОТВОРЕНИЕ У КАЗАХСКОГО БЕЛОГОЛОВОГО СКОТА

Source: Ġylym ža̋ne bìlìm. 1:112-222

2

The influence of gender and age characteristics on attitudes towards assisted reproductive technologies

Source: Society and Security Insights; Vol 8 No 2 (2025): Regular Issue; 75-88
Society and Security Insights; Том 8 № 2 (2025): Основной выпуск; 75-88

Subject Terms: childlessness, demography, суррогатное материнство, бездетность, surrogacy, рождаемость, демография, birth rate, экстракорпоральное оплодотворение, in vitro fertilization

File Description: application/pdf; text/html

Access URL: https://journal.asu.ru/ssi/article/view/17279

View record at OpenAIRE

Nájsť tento článok vo Web of Science

3

Thrombosis risk and in vitro fertilization ; Риск тромбозов и экстракорпоральное оплодотворение

Authors: E. Grandone Э. Грандоне

Source: Obstetrics, Gynecology and Reproduction; Vol 16, No 1 (2022); 90-95 ; Акушерство, Гинекология и Репродукция; Vol 16, No 1 (2022); 90-95 ; 2500-3194 ; 2313-7347

Subject Terms: НМГ, ART, in vitro fertilization, IVF, venous thromboembolism, VTE, pulmonary embolism, PE, low molecular weight heparins, LMWH, ВРТ, экстракорпоральное оплодотворение, ЭКО, венозная тромбоэмболия, ВТЭ, тромбоэмболия легочной артерии, ТЭЛА, низкомолекулярные гепарины

File Description: application/pdf

Relation: https://www.gynecology.su/jour/article/view/1246/996; Mara M., Koryntova D., Rezabek K.et al. Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study. Ceska Gynekol. 2004;69(4):312–6. [Article in Czech].; Grandone E., Colaizzo D., Vergura P. et al. Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod. 2004;19(8):1796–9. https://doi.org/10.1093/humrep/deh346.; Chan W.S., Ginsberg J.S. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot. J Thromb Haemost. 2006;4(8):1673–7. https://doi.org/10.1111/j.1538-7836.2006.02026.x.; Chan W.S. The ‘ART’of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–18. https://doi.org/10.1097/GCO.0b013e328329c2b8.; Chan W.S., Dixon M.E. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121(6):713–26. https://doi.org/10.1016/j.thromres.2007.05.023.; Piazza G. Oh heavy burden: recognizing the risk of venous thromboembolism in women undergoing assisted reproduction. Thromb Haemost. 2018;118(12):2011–3. https://doi.org/10.1055/s-0038-1676073.; Henriksson P., Westerlund E., Wallen H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:e8632. https://doi.org/10.1136/bmj.e8632.; Sennström M., Rova K., Hellgren M. et al. Thromboembolism and in vitro fertilization–a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–52. https://doi.org/10.1111/aogs.13147.; Marongiu F., Mameli A., Grandone E., Barcellona D. et al. Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? Semin Thromb Hemost. 2019;45(8):778–83. https://doi.org/10.1055/s-0039-1696942.; Grandone E., Di Micco P.P., Villani M. et al. Venous thromboembolism in women undergoing assisted reproductive technologies: data from the RIETE registry. Thromb Hemost. 2018;118(11):1962–8. https://doi.org/10.1055/s-0038-1673402.; Cantwell R., Clutton-Brock T., Cooper G. et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118 Suppl 1:1–203. https://doi.org/10.1111/j.1471-0528.2010.02847.x.; Braat D.D.M., Schutte J.M., Bernardus R.E. et al. Maternal death related to IVF in the Netherlands 1984–2008. Hum Reprod. 2010;25(7):1782–6. https://doi.org/10.1093/humrep/deq080.; Selter J., Huang Y., Becht L.C.G. et al. Use of fertility preservation services in female reproductive-aged cancer patients. Am J Obstet Gynecol. 2019;221(4):328.e1–328.e16. https://doi.org/10.1016/j.ajog.2019.05.009.; Rova K., Passmark H., Lindqvist P.G. et al. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100. https://doi.org/10.1016/j.fertnstert.2011.10.038.; Zore T., Joshi N.V., Lizneva D., Azziz R. Polycystic ovarian syndrome: long-term health consequences. Semin Reprod Med. 2017;35(3):271–81. https://doi.org/10.1055/s-0037-1603096.; Bates S.M., Greer I.A., Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–e736S. https://doi.org/10.1378/chest.11-2300.; Bates S.M., Rajasekhar A., Middeldorp S. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–59. https://doi.org/10.1182/bloodadvances.2018024802.; The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. RCOG, 2016. 22 p. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_5_ohss.pdf.; Lindqvist P.G., Dahlbäck B. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy. Thromb Haemost. 2000;84(7):140–1.; Galambosi P.J., Kaaja R.J., Stefanovi V., Ulander V.-M. et al. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):154–9. https://doi.org/10.1016/j.ejogrb.2012.05.010.; https://www.gynecology.su/jour/article/view/1246